SubscribeThe present survey data provide preliminary evidence to suggest that while clinicians widely regard SSRIs as efficacious in the acute treatment of depression, many observe some degree of relapse during ongoing treatment. Respondents cited a modal frequency of relapse with SSRIs as being between 11% to 25% of cases over 1 year. This group of clinicians believed that depressive symptoms most often re-emerged at approximately 6 months after achieving an initial remission. SSRI dosage increases seem necessary at some point in the course of ongoing treatment in half of cases observed by respondents. …
You are not logged in, either login or create an account to post comments
posted by meeshell at 8:38 AM on November 28, 2007